Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer (clinicaltrials.gov) - Oct 9, 2026 - P2/3 | N=840 | Recruiting | Sponsor: Pfizer | Trial completion date: Jul 2032 ➔ Jan 2033 | Trial primary completion date: Jul 2031 ➔ Jan 2032
Trial completion date • Trial primary completion date • Esophageal Adenocarcinoma • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Oncology • Solid Tumor • HER-2 • PD-L1
|